Format

Send to:

Choose Destination
See comment in PubMed Commons below
Am J Physiol Heart Circ Physiol. 2014 Sep 1;307(5):H670-9. doi: 10.1152/ajpheart.00922.2013. Epub 2014 Jul 3.

Comparison of arterial pressure and plasma ANG II responses to three methods of subcutaneous ANG II administration.

Author information

  • 1Graduate Program in Neuroscience and Department of Integrative Biology and Physiology, University of Minnesota, Minneapolis, Minnesota; and.
  • 2Department of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan.
  • 3Graduate Program in Neuroscience and Department of Integrative Biology and Physiology, University of Minnesota, Minneapolis, Minnesota; and osbor003@umn.edu.

Abstract

Angiotensin II (ANG II)-induced hypertension is a commonly studied model of experimental hypertension, particularly in rodents, and is often generated by subcutaneous delivery of ANG II using Alzet osmotic minipumps chronically implanted under the skin. We have observed that, in a subset of animals subjected to this protocol, mean arterial pressure (MAP) begins to decline gradually starting the second week of ANG II infusion, resulting in a blunting of the slow pressor response and reduced final MAP. We hypothesized that this variability in the slow pressor response to ANG II was mainly due to factors unique to Alzet pumps. To test this, we compared the pressure profile and changes in plasma ANG II levels during subcutaneous ANG II administration (150 ng·kg(-1)·min(-1)) using either Alzet minipumps, iPrecio implantable pumps, or a Harvard external infusion pump. At the end of 14 days of ANG II, MAP was highest in the iPrecio group (156 ± 3 mmHg) followed by Harvard (140 ± 3 mmHg) and Alzet (122 ± 3 mmHg) groups. The rate of the slow pressor response, measured as daily increases in pressure averaged over days 2-14 of ANG II, was similar between iPrecio and Harvard groups (2.7 ± 0.4 and 2.2 ± 0.4 mmHg/day) but was significantly blunted in the Alzet group (0.4 ± 0.4 mmHg/day) due to a gradual decline in MAP in a subset of rats. We also found differences in the temporal profile of plasma ANG II between infusion groups. We conclude that the gradual decline in MAP observed in a subset of rats during ANG II infusion using Alzet pumps is mainly due to pump-dependent factors when applied in this particular context.

Copyright © 2014 the American Physiological Society.

KEYWORDS:

Alzet minipump; angiotensin II-salt hypertension; iPrecio pump; plasma angiotensin II; salt-sensitive hypertension

PMID:
24993045
[PubMed - indexed for MEDLINE]
PMCID:
PMC4187401
[Available on 2015-09-01]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk